91 related articles for article (PubMed ID: 9930993)
1. Spontaneous propeptide processing of mini-stromelysin-1 mutants blocked by APMA ((4-Aminophenyl)mercuric acetate).
Galazka G; Windsor LJ; Birkedal-Hansen H; Engler JA
Biochemistry; 1999 Jan; 38(4):1316-22. PubMed ID: 9930993
[TBL] [Abstract][Full Text] [Related]
2. APMA (4-aminophenylmercuric acetate) activation of stromelysin-1 involves protein interactions in addition to those with cysteine-75 in the propeptide.
Galazka G; Windsor LJ; Birkedal-Hansen H; Engler JA
Biochemistry; 1996 Aug; 35(34):11221-7. PubMed ID: 8780527
[TBL] [Abstract][Full Text] [Related]
3. The latency of the human fibroblast collagenase precursor depends on an internal cysteine residue.
Engler JA; Windsor LJ; Birkedal-Hansen B; Birkedal-Hansen H
Matrix Suppl; 1992; 1():231-6. PubMed ID: 1480032
[TBL] [Abstract][Full Text] [Related]
4. Disruption of the cysteine-75 and zinc ion coordination is not sufficient to activate the precursor of human matrix metalloproteinase 3 (stromelysin 1).
Chen LC; Noelken ME; Nagase H
Biochemistry; 1993 Oct; 32(39):10289-95. PubMed ID: 8399171
[TBL] [Abstract][Full Text] [Related]
5. Activation of the 92-kDa gelatinase by stromelysin and 4-aminophenylmercuric acetate. Differential processing and stabilization of the carboxyl-terminal domain by tissue inhibitor of metalloproteinases (TIMP).
Shapiro SD; Fliszar CJ; Broekelmann TJ; Mecham RP; Senior RM; Welgus HG
J Biol Chem; 1995 Mar; 270(11):6351-6. PubMed ID: 7890773
[TBL] [Abstract][Full Text] [Related]
6. Improvement of extracellular production of a thermophilic subtilase expressed in Escherichia coli by random mutagenesis of its N-terminal propeptide.
Fang N; Zhong CQ; Liang X; Tang XF; Tang B
Appl Microbiol Biotechnol; 2010 Feb; 85(5):1473-81. PubMed ID: 19697018
[TBL] [Abstract][Full Text] [Related]
7. Characterization of structural determinants and molecular mechanisms involved in pro-stromelysin-3 activation by 4-aminophenylmercuric acetate and furin-type convertases.
Santavicca M; Noel A; Angliker H; Stoll I; Segain JP; Anglard P; Chretien M; Seidah N; Basset P
Biochem J; 1996 May; 315 ( Pt 3)(Pt 3):953-8. PubMed ID: 8645182
[TBL] [Abstract][Full Text] [Related]
8. Stepwise activation mechanisms of the precursor of matrix metalloproteinase 3 (stromelysin) by proteinases and (4-aminophenyl)mercuric acetate.
Nagase H; Enghild JJ; Suzuki K; Salvesen G
Biochemistry; 1990 Jun; 29(24):5783-9. PubMed ID: 2383557
[TBL] [Abstract][Full Text] [Related]
9. Critical role of glutamic acid 202 in the enzymatic activity of stromelysin-1 (MMP-3).
Arza B; De Maeyer M; Félez J; Collen D; Lijnen HR
Eur J Biochem; 2001 Feb; 268(3):826-31. PubMed ID: 11168424
[TBL] [Abstract][Full Text] [Related]
10. Beta-hematin interaction with the hemopexin domain of gelatinase B/MMP-9 provokes autocatalytic processing of the propeptide, thereby priming activation by MMP-3.
Geurts N; Martens E; Van Aelst I; Proost P; Opdenakker G; Van den Steen PE
Biochemistry; 2008 Feb; 47(8):2689-99. PubMed ID: 18237197
[TBL] [Abstract][Full Text] [Related]
11. Matrilysin-2, a new matrix metalloproteinase expressed in human tumors and showing the minimal domain organization required for secretion, latency, and activity.
Uría JA; López-Otín C
Cancer Res; 2000 Sep; 60(17):4745-51. PubMed ID: 10987280
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of Ca2+-dependent activity of human neutrophil gelatinase B.
Bu CH; Pourmotabbed T
J Biol Chem; 1996 Jun; 271(24):14308-15. PubMed ID: 8662913
[TBL] [Abstract][Full Text] [Related]
13. Expression, characterization and structure determination of an active site mutant (Glu202-Gln) of mini-stromelysin-1.
Steele DL; El-Kabbani O; Dunten P; Windsor LJ; Kammlott RU; Crowther RL; Michoud C; Engler JA; Birktoft JJ
Protein Eng; 2000 Jun; 13(6):397-405. PubMed ID: 10877850
[TBL] [Abstract][Full Text] [Related]
14. Crystal structure of the stromelysin catalytic domain at 2.0 A resolution: inhibitor-induced conformational changes.
Chen L; Rydel TJ; Gu F; Dunaway CM; Pikul S; Dunham KM; Barnett BL
J Mol Biol; 1999 Oct; 293(3):545-57. PubMed ID: 10543949
[TBL] [Abstract][Full Text] [Related]
15. The occluding loop in cathepsin B defines the pH dependence of inhibition by its propeptide.
Quraishi O; Nägler DK; Fox T; Sivaraman J; Cygler M; Mort JS; Storer AC
Biochemistry; 1999 Apr; 38(16):5017-23. PubMed ID: 10213604
[TBL] [Abstract][Full Text] [Related]
16. Role of zinc-binding- and hemopexin domain-encoded sequences in the substrate specificity of collagenase and stromelysin-2 as revealed by chimeric proteins.
Sanchez-Lopez R; Alexander CM; Behrendtsen O; Breathnach R; Werb Z
J Biol Chem; 1993 Apr; 268(10):7238-47. PubMed ID: 8463259
[TBL] [Abstract][Full Text] [Related]
17. Multiple sites of the propeptide region of human stromelysin-1 are required for maintaining a latent form of the enzyme.
Freimark BD; Feeser WS; Rosenfeld SA
J Biol Chem; 1994 Oct; 269(43):26982-7. PubMed ID: 7929438
[TBL] [Abstract][Full Text] [Related]
18. Cloning and expression of the cathepsin F-like cysteine protease gene in Escherichia coli and its characterization.
Joo HS; Koo KB; Park KI; Bae SH; Yun JW; Chang CS; Choi JW
J Microbiol; 2007 Apr; 45(2):158-67. PubMed ID: 17483802
[TBL] [Abstract][Full Text] [Related]
19. Human fibroblast stromelysin catalytic domain: expression, purification, and characterization of a C-terminally truncated form.
Marcy AI; Eiberger LL; Harrison R; Chan HK; Hutchinson NI; Hagmann WK; Cameron PM; Boulton DA; Hermes JD
Biochemistry; 1991 Jul; 30(26):6476-83. PubMed ID: 1647201
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the 46-kDa intermediates of matrix metalloproteinase 3 (stromelysin 1) obtained by site-directed mutation of phenylalanine 83.
Benbow U; Butticè G; Nagase H; Kurkinen M
J Biol Chem; 1996 May; 271(18):10715-22. PubMed ID: 8631880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
